CN1188641A - A kind of external skin cream with physiotherapy effect - Google Patents
A kind of external skin cream with physiotherapy effect Download PDFInfo
- Publication number
- CN1188641A CN1188641A CN97106241A CN97106241A CN1188641A CN 1188641 A CN1188641 A CN 1188641A CN 97106241 A CN97106241 A CN 97106241A CN 97106241 A CN97106241 A CN 97106241A CN 1188641 A CN1188641 A CN 1188641A
- Authority
- CN
- China
- Prior art keywords
- skin
- facial
- cream
- far infrared
- perlite powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002884 skin cream Substances 0.000 title claims abstract 6
- 238000000554 physical therapy Methods 0.000 title claims abstract 3
- 230000000694 effects Effects 0.000 title abstract description 10
- 239000006071 cream Substances 0.000 claims abstract description 48
- 239000000843 powder Substances 0.000 claims abstract description 20
- 239000010451 perlite Substances 0.000 claims abstract description 17
- 235000019362 perlite Nutrition 0.000 claims abstract description 17
- 239000000203 mixture Substances 0.000 claims abstract description 16
- URLJKFSTXLNXLG-UHFFFAOYSA-N niobium(5+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Nb+5].[Nb+5] URLJKFSTXLNXLG-UHFFFAOYSA-N 0.000 claims abstract description 12
- BPUBBGLMJRNUCC-UHFFFAOYSA-N oxygen(2-);tantalum(5+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5] BPUBBGLMJRNUCC-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229910000484 niobium oxide Inorganic materials 0.000 claims abstract description 9
- 229910001936 tantalum oxide Inorganic materials 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 229910004298 SiO 2 Inorganic materials 0.000 claims description 2
- 238000002425 crystallisation Methods 0.000 claims description 2
- 230000008025 crystallization Effects 0.000 claims description 2
- 238000005245 sintering Methods 0.000 claims description 2
- 229910018072 Al 2 O 3 Inorganic materials 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 230000001815 facial effect Effects 0.000 abstract description 63
- 230000004060 metabolic process Effects 0.000 abstract description 8
- 230000009759 skin aging Effects 0.000 abstract description 7
- 210000003205 muscle Anatomy 0.000 abstract description 5
- 238000003756 stirring Methods 0.000 abstract description 5
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 230000000699 topical effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 49
- 239000000470 constituent Substances 0.000 description 23
- 230000006870 function Effects 0.000 description 9
- 230000001225 therapeutic effect Effects 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 206010043189 Telangiectasia Diseases 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 208000009056 telangiectasis Diseases 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 229960003500 triclosan Drugs 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- NMJJFJNHVMGPGM-UHFFFAOYSA-N butyl formate Chemical compound CCCCOC=O NMJJFJNHVMGPGM-UHFFFAOYSA-N 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 239000000701 coagulant Substances 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- PKKOWLGKLOFORY-UHFFFAOYSA-N OCC1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O.OCC1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O Chemical compound OCC1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O.OCC1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O PKKOWLGKLOFORY-UHFFFAOYSA-N 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
A topical skin cream with physical therapy effect is prepared by mixing composition capable of releasing far infrared ray in specific ratio of 4% into various creams on the market, and stirring. The composition comprises 70-90% of perlite powder, 7-20% of tantalum oxide and 3-10% of niobium oxide. The facial cream can effectively dilate capillary vessels of facial skin, thereby eliminating stiffness, relaxation and soreness of skin and muscle, preventing skin aging, promoting metabolism, moistening skin, massaging skin, and making facial skin more elastic.
Description
The present invention is relevant a kind of external facial cream for skin with physical therapeutic function, be to mix on the market with special ratios and form in the various facial creams furtherly with having releasing far infrared constituent, eliminate the stiff, loose of face and ache to reach, prevent skin aging, enhance metabolism, skin care and have the effect of massage skin.
The employed facial cream of women can be divided into day cream, late frost and dryness and the employed facial cream of oily skin at present, and when these facial creams use, women facial cream mat finger is smeared and evenly spreading on the face, allow in the pore of facial cream porous skin, remove the foul in the pore or prevent skin aging, enhance metabolism, skin care, the sensation that skin is had live again again, thereby facial cream has become the indispensable toiletware of women.
Yet, though above-mentioned various facial creams improve significantly to skin, but improved ageing be of short duration, it is not the improvement of chronicity, therefore most women also the another kind of face frost that applies of membership be applied on the face, with the skin that improves face again, so women just can use multiple facial cream for the skin that improves face, and cause the change expense of money writing, and also may not necessarily be improved.And some facial cream also can make the facial skin of user have minus effect hypersensitive to produce, and cause injuring the user facial skin under the situation of user improper use.
For this reason, the object of the invention provides a kind of external facial cream for skin with physical therapeutic function, the constituent that can discharge far infrared that contains a special ratios in this facial cream, can make the telangiectasis of facial skin effectively, thereby eliminate the stiff, loose of facial skin muscle and ache, can also prevent skin aging, enhance metabolism, skin care and have the effect of massage skin, can make the skin of face have more elasticity.
The invention provides a kind of external facial cream for skin with physical therapeutic function, is to mix in forming in the various on the market facial creams at present with special ratios by releasing far infrared constituent having.This constituent comprises perlite powder, tantalum oxide (Ta
2O
5) and niobium oxide (Nb
2O
5), its releasable far infrared wavelength is 3～16 microns for being suitable for human body.
In order to overcome the shortcoming that existing facial cream exists, the present invention has confirmed that according to medical circle far infrared has the function of activating cell, and " far-infrared ray ceramic to human neutrophils, the influence of lymph corpuscle activation ".And can heat to absorb heat energy releasing far infrared by mat at more known potteries, under the irradiation of human body skin at this far infrared, can present various effects, for example: the temperature of rising lower epidermis layer depth portion, the expansion blood capillary, blood circulation promoting and metabolism, loose sensory nerve and adjusting autonomic nervous system etc.
And according to the constituent of above-mentioned far-infrared ray ceramic, be belong in the volcanic rock perlite powder in 1100 ℃ to 1300 ℃ fired after, form with the tantalum oxide and the niobium oxide of special ratios, when human body touches this far infrared, can discharge the far infrared that is suitable for body scale by body temperature, and the amount that is discharged just makes 1.3 to 1.4 times of telangiectasis.
Based on above-mentioned basis, the invention provides a kind of external facial cream for skin with physical therapeutic function, contain the releasing far infrared constituent of an energy in this facial cream, this constituent comprises 70% to 90% perlite powder, 7% to 20% tantalum oxide (Ta
2O
5) and 3% to 10% niobium oxide (Nb
2O
5).Perlite powder is that purity is more than 99.9% and granularity is 7 to 8 microns a sintered powder, and this perlitic composition comprises 73.41%SiO
2, 12.34%Al
2O
3, 2.27%Fe
2O
3, 2.95%Na
2O, 5.33%K
2O, and 3.70% water of crystallization.
Above-mentioned perlite powder is in three hours fine-powders to eight hours gained of 1100 ℃ to 1300 ℃ sintering, can discharge 3 to 16 microns far infrared under low temperature (temperature of about facial skin) heating.
In perlite powder is formed, be added with the high-purity mangesium oxide tantalum and the niobium oxide of special ratios, can increase the burst size of the far infrared of perlite powder.This be added into tantalum oxide in the perlite powder and niobium oxide be purity be 99.99% and granularity be 17 to 20 microns high purity powdered form.
The constituent that above-mentioned energy is releasing far infrared mixes in various on the market facial creams at present with 4% specific ratio, evenly stir the present invention have the external facial cream for skin of physical therapeutic function.
The above-mentioned external facial cream for skin of finishing in use, as long as facial cream is coated on facial skin, the constituent that the energy that contains in this facial cream is releasing far infrared just can produce the far infrared of one 3 to 16 micron wave lengths, and the wavelength of this scope is to have strong thermoresonance effect.When this constituent contacts with facial skin, the temperature of mat facial skin can discharge far infrared, the far infrared that is discharged can be absorbed into depths under the facial skin, make the activity of ICW more become active, and then impel the expansion of blood capillary, thereby eliminate the stiff, loose of facial skin muscle and ache, and can also prevent skin aging, enhance metabolism and skin care, make facial skin have more elasticity.
Therefore, when the inventor is coated on this external facial cream for skin with physical therapeutic function of finishing on the facial skin, after after a while, this perlite powder, tantalum oxide and niobium oxide constituent, thereby promptly can make telangiectasis eliminate the stiff, loose of facial skin muscle and ache, can also prevent skin aging, enhance metabolism and skin care, make facial skin have more elasticity.Therefore, of the present invention have the constituent that discharges far infrared and not only apply on the facial cream, connects in the skin protection cosmetics of general mud shape or paste or the hair care agent and also can add this constituent.
Advantage of the present invention: a kind of external facial cream for skin with physical therapeutic function is to mix in forming in the various on the market facial creams at present with specific ratio by releasing far infrared constituent having.When allowing user be coated on the face, except the effect of facial cream of itself, but and the far infrared that discharged of mat aforementioned component thing make the telangiectasis of facial skin, thereby can eliminate the stiff, loose of facial skin muscle and ache.Can also prevent skin aging, enhance metabolism and skin care, make facial skin have more elasticity.In addition, external facial cream for skin of the present invention does not have any pair of effect in use and produces the use that can allow user feel at ease.
Various on the market at present facial creams are various in style, and its composition also is ever-changing, and the invention will be further described with following listed examples, and still, the present invention is not limited to these embodiment.In addition, each components contents percentage ratio of writing all is meant weight % among the present invention.
Embodiment 1
(a). can releasing far infrared constituent composed as follows:
(b). external facial cream for skin of the present invention composed as follows:
| Title | Percentage composition (%) |
| Perlite powder | ????70 |
| Tantalum oxide | ????20 |
| Niobium oxide | ????10 |
| Title | Percentage composition (%) |
| Water | ????65.20 |
| Hexadecanol | ????2.00 |
| Glycerol | ????3.50 |
| Adeps Bovis seu Bubali resin (Shea butter) | ????7.00 |
| Paraffin oil | ????8.00 |
| Hard ester acid | ????2.00 |
| Aromatic | ????0.10 |
| Triethanolamine | ????0.90 |
| Methyl butex | ????0.20 |
| Propylparaben | ????0.10 |
| Propylene glycol | ????5.00 |
| Titanium dioxide | ????2.00 |
| Constituent that can be releasing far infrared | ????4.00 |
To mix in all the other components (example of facial cream compositions on the market) in facial cream of the present invention by the releasing far infrared constituent of energy of (a) preparation, see (b), and evenly stirring external facial cream for skin of the present invention.
Embodiment 2.
(c). can releasing far infrared constituent composed as follows:
| Title | Percentage composition (%) |
| Perlite powder | ????90 |
| Tantalum oxide | ????7 |
| Niobium oxide | ????3 |
(d). external facial cream for skin of the present invention composed as follows:
| Title | Percentage composition (%) |
| Water | ????60.28 |
| ????C12-20?acid?PEG-8?ester | ????15.00 |
| Mineral oil | ????5.50 |
| Vaseline (petrolatum) | ????5.00 |
| Acetylated lanolin (acetylated lanolin) | ????2.00 |
| Gulfweed extract (horsetail extract) | ????1.00 |
| Triethanolamine | ????1.55 |
| The vigorous Piao of card (cabopol makes coagulant and uses) | ????1.50 |
| Potassium cetyl phosphate (potassium cetyl phosphate) | ????0.45 |
| Phenoxyethanol | ????1.42 |
| Aromatic | ????0.25 |
| Imidazolidinyl urea (imidazolidinyl urea) | ????1.22 |
| Triclosan (triclosan) | ????0.83 |
| Constituent that can be releasing far infrared | ????4.00 |
To mix in all the other components (example of facial cream compositions on the market) in facial cream of the present invention by the releasing far infrared constituent of energy of (c) preparation, see (d), and evenly stirring external facial cream for skin of the present invention.
Embodiment 3
(e). can releasing far infrared constituent composed as follows:
| Title | Percentage composition (%) |
| Perlite powder | ????80 |
| Tantalum oxide | ????14 |
| Niobium oxide | ????6 |
External facial cream for skin of the present invention composed as follows:
| Title | Percentage composition (%) |
| Water | ????74.18 |
| Mineral oil | ????4.68 |
| ????C12-20?acid?PEG-8?ester | ????5.50 |
| Propylene glycol | ????2.75 |
| Vaseline | ????3.00 |
| The gulfweed extract | ????1.50 |
| Acetylated lanolin | ????1.00 |
| Triethanolamine | ????0.45 |
| Imidazolidinyl urea | ????0.22 |
| Aromatic | ????0.20 |
| Triclosan | ????0.75 |
| The vigorous Piao of card (cabopol makes coagulant and uses) | ????0.45 |
| Potassium cetyl phosphate | ????0.45 |
| Squalane (squalane) | ????0.45 |
| The oxybenzene butyl formate | ????0.42 |
| Constituent that can be releasing far infrared | ????4.00 |
To mix in all the other components (example of facial cream compositions on the market) in facial cream of the present invention by the releasing far infrared constituent of energy of (e) preparation, see (f), and evenly stirring external facial cream for skin of the present invention.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97106241A CN1188641A (en) | 1997-01-23 | 1997-01-23 | A kind of external skin cream with physiotherapy effect |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97106241A CN1188641A (en) | 1997-01-23 | 1997-01-23 | A kind of external skin cream with physiotherapy effect |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1188641A true CN1188641A (en) | 1998-07-29 |
Family
ID=5168503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97106241A Pending CN1188641A (en) | 1997-01-23 | 1997-01-23 | A kind of external skin cream with physiotherapy effect |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1188641A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010054921A1 (en) | 2008-11-17 | 2010-05-20 | L'oreal | Cosmetic method for treating human perspiration using particles of an expanded amorphous mineral material; compositions |
-
1997
- 1997-01-23 CN CN97106241A patent/CN1188641A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010054921A1 (en) | 2008-11-17 | 2010-05-20 | L'oreal | Cosmetic method for treating human perspiration using particles of an expanded amorphous mineral material; compositions |
| EP2358444B1 (en) | 2008-11-17 | 2016-12-28 | L'Oréal | Cosmetic method for treating human perspiration using particles of an expanded amorphous mineral material; compositions. |
| US11266583B2 (en) | 2008-11-17 | 2022-03-08 | L'oreal | Cosmetic method for treating human perspiration using particles of an expanded amorphous mineral material; compositions |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7179477B2 (en) | Cosmetic dermabrasion treatment system | |
| JP2002512971A5 (en) | ||
| US8784875B2 (en) | Collagen for use in the treatment of skin diseases | |
| KR102307509B1 (en) | Composition for hairloss and scalp care | |
| US6645473B2 (en) | Combination tanning and antifungal topical system for treating tinea versicolor | |
| CN101569640A (en) | Application of total asiaticoside to preparation of medicaments or cosmetics for preventing and curing striae gravidarum | |
| US20010001666A1 (en) | Liquid skin treatment | |
| JP2010241762A (en) | Cosmetic | |
| US5571516A (en) | Bath medicine | |
| JP2007519730A (en) | Sensory exfoliation system without damaging the surface | |
| CN106511211B (en) | Anti-inflammatory acne-removing skin-care lotion and preparation method thereof | |
| JP2958662B2 (en) | Hair growth and hair growth promoter | |
| CN111514087A (en) | Whitening and skin-brightening composition and preparation method thereof | |
| CN111514055A (en) | Cosmetic polypeptide composition granules with anti-inflammatory repair effect | |
| CN1188641A (en) | A kind of external skin cream with physiotherapy effect | |
| US20010014343A1 (en) | Skin care composition | |
| CN102485197A (en) | External facial cream having physical therapy effects | |
| US20010001665A1 (en) | Cream compositions for skin management | |
| KR101127190B1 (en) | Cosmetic composition containing medical plant feeling powder | |
| CN111419770A (en) | Moisturizing and repairing type temperature-sensitive awakening facial mask and preparation method thereof | |
| KR101248520B1 (en) | Cream cosmetics composition containing crystal powder | |
| TWI704930B (en) | Set for deep cleaning pores and method for deep cleaning pores | |
| JPH09263528A (en) | Cosmetic | |
| CN105963186A (en) | Beautifying ultrasonic coupling agent and preparation method and application thereof | |
| KR100809488B1 (en) | Composition of sheet type hydrogel pack and method of manufacturing sheet type hydrogel pack using same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |